Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

COMMON STOCK · CUSIP: 09058V103

Event date: 2026-09-30

Filing-level shares
12,294,412.00
Percent of class
4.8%
  • STATE STREET CORPORATION

    Shares: 12,294,412.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000622
Form type
SCHEDULE 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub